Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones
    2.
    发明授权
    Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones 有权
    含有三唑酮的药物组合物和使用三唑酮治疗神经变性疾病的方法

    公开(公告)号:US06492407B2

    公开(公告)日:2002-12-10

    申请号:US09840281

    申请日:2001-04-23

    IPC分类号: A61K3141

    CPC分类号: C07D401/04 C07D249/12

    摘要: A method for treating a neurodegenerative disease or cerebral ischemia arising from conditions selected from the group consisting of Status epilepticus, hypoglycaemia, hypoxia, anoxia, brain trauma, brain oedema, amyotropic lateral sclerosis, Huntington's disease, Alzheimer's disease, hypotonia, cardiac infarction, brain pressure (elevated intracranial pressure), ischaemic and haemorrhagic stroke, global cerebral ischaemia with heart stoppage, diabetic polyneuropathy, tinnitus, perinatal asphyxia, psychosis, schizophrenia, depression, and Parkinson's disease, the method of treatment comprising administering to a host in need of such treatment a therapeutic amount of a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions containing a compound of formula (I).

    摘要翻译: 一种用于治疗由选自癫痫持续状态,低血糖,缺氧,缺氧,脑外伤,脑水肿,肌萎缩性侧索硬化,亨廷顿舞蹈病,阿尔茨海默氏病,低张力,心肌梗死,脑中的病症引起的神经变性疾病或脑缺血的方法 压力(颅内压升高),缺血性和出血性中风,心脏停止的全球性脑缺血,糖尿病性多发性神经病,耳鸣,围产期窒息,精神病,精神分裂症,抑郁症和帕金森病,治疗方法包括向需要这种 治疗治疗量的式(I)化合物,其中R 1,R 2,R 3,R 4,R 5,R 6和R 7如本文所定义,或其药学上可接受的盐,以及含有式(I)化合物的药物组合物, 。

    METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISORDERS
    6.
    发明申请
    METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISORDERS 审中-公开
    预防和治疗神经损伤性疾病的方法

    公开(公告)号:US20100081625A1

    公开(公告)日:2010-04-01

    申请号:US12524220

    申请日:2008-01-25

    IPC分类号: A61K31/70 A61P25/28

    CPC分类号: A61K31/351 A61K31/70

    摘要: The present invention relates to a method for treating, preventing or slowing, delaying or reversing progression of one or more neurodegenerative disorders in a patient in need thereof characterized by administering a glucopyranosyl-substituted benzene derivative, a tautomer, stereoisomer, mixture or salt thereof, as defined in claim 1 to the patient in need thereof.

    摘要翻译: 本发明涉及一种治疗,预防或减缓延迟或逆转有需要的患者中一种或多种神经变性疾病进展的方法,其特征在于给予吡喃葡萄糖基取代的苯衍生物,互变异构体,立体异构体,其混合物或盐, 如权利要求1所限定的,对有需要的患者。